[ sulge aken ]
| Elulookirjeldus (CV) | ||
| 1. | Eesnimi | Veiko |
| 2. | Perekonnanimi | Vasar |
| 3. | Töökoht | Tartu Ülikool, psühhiaatriakliinik |
| 4. | Ametikoht | kliiniku juhataja |
| 5. | Sünniaeg | 16.01.1956 (päev.kuu.aasta) |
| 6. | Haridus | Tartu Ülikool, Arstiteaduskond, 1979 |
| 7. | Teenistuskäik | 2000- SA TÜ Kliinikumi psühhiaatriakliiniku juhataja 1999- psühhiaatria professor 1992- TÜ psühhiaatriakliiniku juhataja 1990-1999 TÜ psühhiaatria kateedri dotsent 1985-1990 TÜ psühhiaatria kateedri assistent 1980-1985 TÜ ÜMPI teadur 1979-1980 psühhiaatria internatuur |
| 8. | Teaduskraad | meditsiinikandidaat |
| 9. | Teaduskraadi välja andnud asutus, aasta |
Tartu Ülikool, 1987 |
| 10. | Tunnustused | |
| 11. | Teadusorganisatsiooniline ja –administratiivne tegevus |
TÜ arstiteaduskonna nõukogu liige; Eesti Teadusfondi nõukogu liige; Eesti Psühhiaatrite Assotsatsiooni juhatuse liige, aseesimees; Sotsiaalministeeriumi psühhiaatria erialakomisjoni liige; |
| 12. | Juhendamisel kaitstud väitekirjad |
Eduard Maron, PhD, 2004, juh. Veiko Vasar, Jakov Shlik. Serotonin functioning in panic disorder: from clinical experiments to brain imaging and genetics. Tartu Ülikol Anu Aluoja, PhD, 2002, juh. Veiko Vasar. Depression in the population: assessment, prevalence and relationships with socio-demographic factors and cognitive aspect of social adjustment. Tartu Ülikool Marlit Veldi, PhD, 2001, juh. Veiko Vasar, Mart Kull. Obstructive Sleep Apnoea: Computerized Endopharyngeal Myotonometry of the Soft Palate and Lingual Musculature. Tartu Ülikool Jakov Shlik, PhD, 1999, juh. Veiko Vasar. Psychophysiological effects of cholecystokinin in humans. Tartu Ülikool Sergei Pakrijev, PhD, 1998, juh. Veiko Vasar, Märt Saarma. Prevalence of depression, harmful use of alcohol and alcohol dependence among rural population in Udmurtia. Tartu Ülikool |
| 13. | Teadustöö põhisuunad | Meeleolu ja ärevushäirete neurobioloogia; Unehäired; |
| 14. | Jooksvad grandid | 01.01.2003 - 31.12.2007 Psüühikahäirete epidemioloogia, geneetilised tegurid ja patogeneesi mehhanismid (SF0182590As03) |
| 15. | Teaduspublikatsioonid |
Koido, K., Koks, S., Nikopensius, T., Maron, E., Altmae, S., Heinaste, E., Vabrit, K., Tammekivi, V., Hallast, P., Kurg, A., Shlik, J., Vasar, V., Metspalu, A., Vasar, E.: Polymorphisms in wolframin (WFS1) gene are possibly related to increased risk for mood disorders - INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2005, Vol. 8, No. 2, 235-244 Koks S, Nikopensius T, Koido K, Maron E, Altmae S, Heinaste E, Vabrit K, Tammekivi V, Hallast P, Kurg A, Shlik J, Vasar V, Metspalu A, Vasar E. Analysis of SNP profiles in patients with major depressive disorder. Int J Neuropsychopharmacol. 2005 Jun 1;:1-8 Maron E, Lang A, Tasa G, Liivlaid L, Toru I, Must A, Vasar V, Shlik J. Associations between serotonin-related gene polymorphisms and panic disorder. Int J Neuropsychopharmacol. 2005 Jun;8(2):261-6. Maron E, Nikopensius T, Koks S, Altmae S, Heinaste E, Vabrit K, Tammekivi V, Hallast P, Koido K, Kurg A, Metspalu A, Vasar E, Vasar V, Shlik J. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet. 2005 Mar;15(1):17-24. Veldi, M., Aluoja, A., Vasar, V.: Sleep quality and more common sleep-related problems in medical students - SLEEP MEDICINE, 2005, Vol. 6, No. 3, 269-275 Aluoja, A., Leinsalu, M., Shlik, J., Vasar, V., Luuk, K.: Symptoms of depression in the Estonian population: prevalence, sociodemographic correlates and social adjustment - JOURNAL OF AFFECTIVE DISORDERS, 2004, Vol. 78, No. 1, 27-35 Maron E, Kuikka JT, Shlik J, Vasar V, Vanninen E, Tiihonen J. Reduced brain serotonin transporter binding in patients with panic disorder. Psychiatry Res. 2004 Dec 15;132(2):173-81. Maron, E., Kuikka, JT., Ulst, K., Tiihonen, J., Vasar, V., Shlik, J.: SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder - EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2004, Vol. 254, No. 6, 392-396 Maron E, Tasa G, Toru I, Lang A, Vasar V, Shlik J. Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers. World J Biol Psychiatry. 2004 Jul;5(3):149-54. Maron, E., Toru, I., Vasar, V., Shlik, J.: The effect of 5-hydroxytryptophan on chotecystokinin-4-induced panic attacks in healthy volunteers - JOURNAL OF PSYCHOPHARMACOLOGY, 2004, Vol. 18, No. 2, 194-199 Shlik, J., Maron, E., Toru, I., Aluoja, A., Vasar, V.: Citalopram challenge in social anxiety disorder - INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, Vol. 7, No. 2, 177-182 Jaanson, P., Marandi, T., Kiivet, RA., Vasar, V., Vaan, S., Svensson, JO., Dahl, ML.: Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype - PSYCHOPHARMACOLOGY, 2002, Vol. 162, No. 1, 67-73 Veldi, M., Vasar, V., Hion, T., Vain, A., Kull, M.: Myotonometry demonstrates changes of lingual musculature in obstructive sleep apnoea - EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2002, Vol. 259, No. 2, 108-112 Pakriev, S., Shlik, J., Vasar, V.: Course of depression: Findings from a cross-sectional survey in rural Udmurtia - NORDIC JOURNAL OF PSYCHIATRY, 2001, Vol. 55, No. 3, 185-189 Veldi, M., Vasar, V., Hion, T., Kull, M., Vain, A.: Ageing, soft-palate tone and sleep-related breathing disorders - CLINICAL PHYSIOLOGY, 2001, Vol. 21, No. 3, 358-364 Koks, S., Mannisto, PT., Bourin, M., Shlik, J., Vasar, V., Vasar, E.: Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations - JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2000, Vol. 25, No. 1, 33-42 Veldi, M., Vasar, V., Vain, A., Hion, T., Kull, M.: Computerized endopharyngeal myotonometry (CEM): A new method to evaluate the tissue tone of the soft palate in patients with obstructive sleep apnoea syndrome - JOURNAL OF SLEEP RESEARCH, 2000, Vol. 9, No. 3, 279-284 Pakriev, S., Vasar, V., Aluoja, A., Saarma, M., Shlik, J.: Prevalence of mood disorders in the rural population of Udmurtia - ACTA PSYCHIATRICA SCANDINAVICA, 1998, Vol. 97, No. 3, 169-174 Pakriev, S., Vasar, V., Aluoja, A., Shlik, J.: Prevalence of ICD-10 harmful use of alcohol and alcohol dependence among the rural population in Udmurtia - ALCOHOL AND ALCOHOLISM, 1998, Vol. 33, No. 3, 255-264 Aluoja, A., Shlik, J., Vasar, V., Kingisepp, PH., Jagomagi, K., Vasar, E., Bradwejn, J.: Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers - PSYCHIATRY RESEARCH, 1997, Vol. 66, No. 1, 59-67 Shlik, J., Aluoja, A., Vasar, V., Vasar, E., Podar, T., Bradwejn, J.: Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder - JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1997, Vol. 22, No. 5, 332-340 Shlik, J., Vasar, V., Aluoja, A., Kingisepp, PH., Jagomagi, K., Vasar, E., Rago, L., Bradwejn, J.: The effect of cholecystokinin tetrapeptide on respiratory resistance in healthy volunteers - BIOLOGICAL PSYCHIATRY, 1997, Vol. 42, No. 3, 206-212 Vasar, V., Appelberg, B., Rimon, R., Selvaratnam, J.: The effect of fluoxetine on sleep - a longitudinal, double-blind polysomnographic study of healthy-volunteers - INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1994, Vol. 9, No. 3, 203-206 |
viimati muudetud: 08.08.2005
| Curriculum Vitae (CV) | ||
| 1. | First Name | Veiko |
| 2. | Surname | Vasar |
| 3. | Institution | University of Tartu, Department of Psychiatry |
| 4. | Position | Head of the department |
| 5. | Date of birth | 16.01.1956 (day.month.year) |
| 6. | Education | 1979 - University of Tartu, Medical Faculty, M.D. |
| 7. | Research and professional experience |
2000 - date Head, Clinic of Psychiatry, Tartu University Clinics 1999 - date Professor, Department of Psychiatry, University of Tartu 1992 – date Head, Department of Psychiatry, University of Tartu 1990 - 1999 Associate professor, Department of Psychiatry, University of Tartu 1990 – 1991 Research fellow, Department of Psychiatry, University of Helsinki 1985 – 1990 Lecturer, Department of Psychiatry, University of Tartu 1980 - 1985 Research fellow, Laboratory of Clinical and Experimental Psychopharmacology, University of Tartu 1979 –1980 Specialization in psychiatry, Tartu Psychiatric Hospital. |
| 8. | Academic degree | Ph.D., medicine |
| 9. | Dates and sites of earning the degrees |
University of Tartu, 1987 |
| 10. | Honours/awards | |
| 11. | Research-administrative experience |
Member of the Council of the Faculty of Medicine; Member of the Council of Estonian Scientific Foundation; Vice-President of the Estonian Association of Psychiatrists; |
| 12. | Supervised dissertations |
Eduard Maron, PhD, 2004, superv. Veiko Vasar, Jakov Shlik. Serotonin functioning in panic disorder: from clinical experiments to brain imaging and genetics. Tartu Ülikol Anu Aluoja, PhD, 2002, superv. Veiko Vasar. Depression in the population: assessment, prevalence and relationships with socio-demographic factors and cognitive aspect of social adjustment. Tartu Ülikool Marlit Veldi, PhD, 2001, superv. Veiko Vasar, Mart Kull. Obstructive Sleep Apnoea: Computerized Endopharyngeal Myotonometry of the Soft Palate and Lingual Musculature. Tartu Ülikool Jakov Shlik, PhD, 1999, superv. Veiko Vasar. Psychophysiological effects of cholecystokinin in humans. Tartu Ülikool Sergei Pakrijev, PhD, 1998, superv. Veiko Vasar, Märt Saarma. Prevalence of depression, harmful use of alcohol and alcohol dependence among rural population in Udmurtia. Tartu Ülikool |
| 13. | Current research program | Neurobiology of mood and anxiety disorders; sleep disorders; |
| 14. | Current grant funding | 2003-2008 - SF0182590As03 “Epidemiology, genetic factors and pathological mechanisms of mental disorders” |
| 15. | List of most important publications |
Koido, K., Koks, S., Nikopensius, T., Maron, E., Altmae, S., Heinaste, E., Vabrit, K., Tammekivi, V., Hallast, P., Kurg, A., Shlik, J., Vasar, V., Metspalu, A., Vasar, E.: Polymorphisms in wolframin (WFS1) gene are possibly related to increased risk for mood disorders - INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2005, Vol. 8, No. 2, 235-244 Koks S, Nikopensius T, Koido K, Maron E, Altmae S, Heinaste E, Vabrit K, Tammekivi V, Hallast P, Kurg A, Shlik J, Vasar V, Metspalu A, Vasar E. Analysis of SNP profiles in patients with major depressive disorder. Int J Neuropsychopharmacol. 2005 Jun 1;:1-8 Maron E, Lang A, Tasa G, Liivlaid L, Toru I, Must A, Vasar V, Shlik J. Associations between serotonin-related gene polymorphisms and panic disorder. Int J Neuropsychopharmacol. 2005 Jun;8(2):261-6. Maron E, Nikopensius T, Koks S, Altmae S, Heinaste E, Vabrit K, Tammekivi V, Hallast P, Koido K, Kurg A, Metspalu A, Vasar E, Vasar V, Shlik J. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet. 2005 Mar;15(1):17-24. Veldi, M., Aluoja, A., Vasar, V.: Sleep quality and more common sleep-related problems in medical students - SLEEP MEDICINE, 2005, Vol. 6, No. 3, 269-275 Aluoja, A., Leinsalu, M., Shlik, J., Vasar, V., Luuk, K.: Symptoms of depression in the Estonian population: prevalence, sociodemographic correlates and social adjustment - JOURNAL OF AFFECTIVE DISORDERS, 2004, Vol. 78, No. 1, 27-35 Maron E, Kuikka JT, Shlik J, Vasar V, Vanninen E, Tiihonen J. Reduced brain serotonin transporter binding in patients with panic disorder. Psychiatry Res. 2004 Dec 15;132(2):173-81. Maron, E., Kuikka, JT., Ulst, K., Tiihonen, J., Vasar, V., Shlik, J.: SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder - EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2004, Vol. 254, No. 6, 392-396 Maron E, Tasa G, Toru I, Lang A, Vasar V, Shlik J. Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers. World J Biol Psychiatry. 2004 Jul;5(3):149-54. Maron, E., Toru, I., Vasar, V., Shlik, J.: The effect of 5-hydroxytryptophan on chotecystokinin-4-induced panic attacks in healthy volunteers - JOURNAL OF PSYCHOPHARMACOLOGY, 2004, Vol. 18, No. 2, 194-199 Shlik, J., Maron, E., Toru, I., Aluoja, A., Vasar, V.: Citalopram challenge in social anxiety disorder - INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, Vol. 7, No. 2, 177-182 Jaanson, P., Marandi, T., Kiivet, RA., Vasar, V., Vaan, S., Svensson, JO., Dahl, ML.: Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype - PSYCHOPHARMACOLOGY, 2002, Vol. 162, No. 1, 67-73 Veldi, M., Vasar, V., Hion, T., Vain, A., Kull, M.: Myotonometry demonstrates changes of lingual musculature in obstructive sleep apnoea - EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2002, Vol. 259, No. 2, 108-112 Pakriev, S., Shlik, J., Vasar, V.: Course of depression: Findings from a cross-sectional survey in rural Udmurtia - NORDIC JOURNAL OF PSYCHIATRY, 2001, Vol. 55, No. 3, 185-189 Veldi, M., Vasar, V., Hion, T., Kull, M., Vain, A.: Ageing, soft-palate tone and sleep-related breathing disorders - CLINICAL PHYSIOLOGY, 2001, Vol. 21, No. 3, 358-364 Koks, S., Mannisto, PT., Bourin, M., Shlik, J., Vasar, V., Vasar, E.: Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations - JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2000, Vol. 25, No. 1, 33-42 Veldi, M., Vasar, V., Vain, A., Hion, T., Kull, M.: Computerized endopharyngeal myotonometry (CEM): A new method to evaluate the tissue tone of the soft palate in patients with obstructive sleep apnoea syndrome - JOURNAL OF SLEEP RESEARCH, 2000, Vol. 9, No. 3, 279-284 Pakriev, S., Vasar, V., Aluoja, A., Saarma, M., Shlik, J.: Prevalence of mood disorders in the rural population of Udmurtia - ACTA PSYCHIATRICA SCANDINAVICA, 1998, Vol. 97, No. 3, 169-174 Pakriev, S., Vasar, V., Aluoja, A., Shlik, J.: Prevalence of ICD-10 harmful use of alcohol and alcohol dependence among the rural population in Udmurtia - ALCOHOL AND ALCOHOLISM, 1998, Vol. 33, No. 3, 255-264 Aluoja, A., Shlik, J., Vasar, V., Kingisepp, PH., Jagomagi, K., Vasar, E., Bradwejn, J.: Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers - PSYCHIATRY RESEARCH, 1997, Vol. 66, No. 1, 59-67 Shlik, J., Aluoja, A., Vasar, V., Vasar, E., Podar, T., Bradwejn, J.: Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder - JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1997, Vol. 22, No. 5, 332-340 Shlik, J., Vasar, V., Aluoja, A., Kingisepp, PH., Jagomagi, K., Vasar, E., Rago, L., Bradwejn, J.: The effect of cholecystokinin tetrapeptide on respiratory resistance in healthy volunteers - BIOLOGICAL PSYCHIATRY, 1997, Vol. 42, No. 3, 206-212 Vasar, V., Appelberg, B., Rimon, R., Selvaratnam, J.: The effect of fluoxetine on sleep - a longitudinal, double-blind polysomnographic study of healthy-volunteers - INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1994, Vol. 9, No. 3, 203-206 |
last updated: 08.08.2005
[ sulge aken ]